Long-Term Assessment of Bone Regeneration in Nonunion Fractures Treated with Compression-Resistant Matrix and Recombinant Human Bone Morphogenetic Protein-2 in Dogs

Vet Comp Orthop Traumatol. 2023 Jan;36(1):29-38. doi: 10.1055/s-0042-1749451. Epub 2022 Jun 27.

Abstract

Objective: The aim of this study was to assess bone density, bone architecture and clinical function of canine nonunion distal appendicular long bone fractures with a defect treated with fixation, compression-resistant matrix and recombinant human bone morphogenetic protein-2 (rhBMP-2).

Study design: Prospective cohort study with dogs at least 1-year post treatment. Computed tomography was performed and quantitative measurements from previous fracture sites were compared with measurements from contralateral limbs. Subjective evaluation included gait assessment and palpation.

Results: Six patients met the inclusion criteria. The rhBMP-2 treated bone exhibited higher density at the periphery and lower density in the centre, similar to the contralateral limb. All patients were weight bearing on the treated limb and all fractures were healed.

Conclusion: The rhBMP-2-treated bone underwent restoration of normal architecture and density. Acceptable limb function was present in all patients. The results of this study can serve as a basis for long-term response in treating nonunion fractures in veterinary patients.

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2 / therapeutic use
  • Bone Regeneration
  • Dog Diseases* / drug therapy
  • Dogs
  • Fracture Healing
  • Fractures, Bone* / diagnostic imaging
  • Fractures, Bone* / drug therapy
  • Fractures, Bone* / surgery
  • Fractures, Bone* / veterinary
  • Fractures, Ununited* / diagnostic imaging
  • Fractures, Ununited* / drug therapy
  • Fractures, Ununited* / surgery
  • Fractures, Ununited* / veterinary
  • Humans
  • Prospective Studies
  • Recombinant Proteins / therapeutic use
  • Transforming Growth Factor beta / therapeutic use

Substances

  • recombinant human bone morphogenetic protein-2
  • Transforming Growth Factor beta
  • Bone Morphogenetic Protein 2
  • Recombinant Proteins